EUVIMEDEUVIMED entdecken
Crossref

Harmonisation of Sterility Assessment for Autologous Serum Eyedrops in Switzerland

Frank Blaser, Isabelle Meneau, Jana Schneider, Claude Kaufmann iD, Katharina Bracher, Dorothee Wandel, Isabelle Constantin, Ulrich Loesch, Stefanie Deuster, Steffen Zeisberger, Germaine F Korner, Jürg Wiedler und 1 weitere

Klinische Monatsblätter für Augenheilkunde · 01.04.2026 · 243 (04) · 300-305

DOI: 10.1055/a-2778-8637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, erschienen am 01.04.2026. Verfasst von Frank Blaser und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University Hospital Zurich, Switzerland. Hauptthemen laut MEDLINE: Ophthalmic Solutions, Serum, Sterilization, Drug Contamination.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Autologous serum eye drops (ASED) are classified as non-standardisable medicine by Swissmedic. Future approval is dependent on whether manufacturing meets the requirements of the European Pharmacopoeia (Ph. Eur.). Currently there is an effort to harmonise the manufacturing process for ASED in Switzerland, in order to facilitate approval. This includes standardisation of sterility assessment. This study evaluates the relevant sterility testing methods as described in the Ph. Eur. and includes the verification of possible antimicrobial activity of serum and the suitability test of the selected membrane filtration method for serum concentrations of 100%, 50% and 20%.

Methods

For sterility testing of medicinal products, Ph. Eur. specifies membrane filtration (MF) and direct inoculation (DI). Alternative methods such as automated blood culture (ABC) systems may be considered. The methods were systematically evaluated for a Switzerland-wide standard for assessing the sterility of ASED. MF was subjected to a suitability test according to Ph. Eur.

Results

Although inexpensive and fast, ABC, widely used internationally for sterility assessment of ASED, had to be rejected, as none of the laboratories with a Swissmedic licence for sterility testing of finished medicinal products offer an ABC system. In addition, as an alternative method according to Ph. Eur. it would have required complex and expensive validation of the method with proof of accuracy, specificity, limit of detection, robustness, suitability and equivalence to the pharmacopoeia method. As part of the suitability assessment of the DI, serum was found to inhibit the growth of Pseudomonas aeruginosa. DI requires appropriate neutralisation of the antimicrobial activity of the serum prior to sterility testing, which is not possible and therefore DI was not considered suitable. The most expensive and time-consuming method, MF, was selected. Suitability tests were performed in triplicate for Bacillus subtilis, Staphylococcus aureus, Pseudomonas aeruginosa, Clostridium sporogenes, Candida albicans and Aspergillus brasiliensis. MF was deemed suitable for the detection of bacterial and fungal strains, with antimicrobial activity of the product eliminated under the test conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ophthalmic SolutionsSerumSterilizationDrug ContaminationSwitzerlandHumans

Substanzen

Ophthalmic Solutions

Autor:innen und Institutionen

  • Department of Ophthalmology, University Hospital Zurich, Switzerland.
  • Ophthalmology, Lucerne Cantonal Hospital, Switzerland.
  • Hospital Pharmacy, Lucerne Cantonal Hospital, Switzerland.
  • Hospital Pharmacy, University Hospital Bern, Switzerland.
  • Hospital Pharmacy, University Hospital Basel, Switzerland.
  • Blood Transfusion Centre Zurich, Swiss red Cross, Zurich, Switzerland.

ORCID-Profile: Claude Kaufmann, Maximilian Robert Justus Wiest

Zitieren

APA

Blaser, F., Meneau, I., Schneider, J., Kaufmann, C., Bracher, K., Wandel, D., Constantin, I., Loesch, U., Deuster, S., Zeisberger, S., Korner, G. F., Wiedler, J., & Wiest, M. R. J. (2026). Harmonisation of Sterility Assessment for Autologous Serum Eyedrops in Switzerland. Klinische Monatsblätter für Augenheilkunde, 243(04), 300-305. https://doi.org/10.1055/a-2778-8637

Vancouver

Blaser F, Meneau I, Schneider J, Kaufmann C, Bracher K, Wandel D, et al. Harmonisation of Sterility Assessment for Autologous Serum Eyedrops in Switzerland. Klinische Monatsblätter für Augenheilkunde. 2026;243(04):300-305. doi:10.1055/a-2778-8637

BibTeX
@article{Blaser2026,
  author = {Blaser, Frank and Meneau, Isabelle and Schneider, Jana and Kaufmann, Claude and Bracher, Katharina and Wandel, Dorothee and Constantin, Isabelle and Loesch, Ulrich and Deuster, Stefanie and Zeisberger, Steffen and Korner, Germaine F and Wiedler, Jürg and Wiest, Maximilian Robert Justus},
  title = {Harmonisation of Sterility Assessment for Autologous Serum Eyedrops in Switzerland},
  journal = {Klinische Monatsblätter für Augenheilkunde},
  year = {2026},
  volume = {243},
  number = {04},
  pages = {300--305},
  doi = {10.1055/a-2778-8637}
}
Kostenlos starten →